Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	87.66	53.39	28.45
Graham Fair Price	-46.09	15.89	29.48
PEG	813.98	-0.08	< 0.005
Price/Book	-11.33	0.72	0.81
Price/Cash Flow	-25.62	33.89	45.56
Prices/Earnings	172.59	11.03	-4.05
Price/Sales	-30.44	21.12	30.37
Price/FCF	-25.62	33.89	45.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	11.38	0.85	0.76
Operating Margin	-76.94	0.80	-3.45
ROA	-68.43	< 0.005	-0.02
ROE	-0.05	0.02	-67.47
ROIC	-0.06	0.01	-78.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.03	-96.42
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-4.89	1.28	-73.87
EPS QOQ	-4.39	1.31	-70.18
FCF QOQ	-0.24	0.13	-48.67
Revenue QOQ	-0.16	0.20	25.06
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	11.08	0.00	inf
Days Sales Outstanding (DSO)	32.46	16.45	-49.31
Inventory Turnover	8.12	0.00	inf
Debt/Capitalization	0.44	0.46	3.15
Quick Ratio	4.71	3.13	-33.59
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	27.72	26.20	-5.48
Cash	4.44	2.83	-36.33
Capex	< 0.005	< 0.005	49.95
Free Cash Flow	0.49	0.56	12.68
Revenue	0.74	0.89	20.50
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.82	3.38	-29.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.45	26.85	115.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating